# The Potential of MicroRNAs in the Context of Sarcopenic Obesity

## TL;DR

This paper explores how microRNAs could help detect and treat sarcopenic obesity, a condition involving fat gain and muscle loss.

## Contribution

It reviews current knowledge on miRNA expression and function in sarcopenic obesity for potential diagnostic and therapeutic applications.

## Key findings

- MicroRNAs regulate gene expression related to inflammation, metabolism, and muscle health.
- Altered miRNA profiles are observed in sarcopenic obesity patients.
- MiRNAs show potential as early biomarkers for sarcopenic obesity progression.

## Abstract

Sarcopenic obesity (SO) is a complex pathological condition characterized by the simultaneous presence of excessive adipose tissue and the loss of muscle mass and strength. This combination leads to an increased risk of metabolic, cardiovascular, and functional complications. In recent years, there has been growing interest in the use of microRNAs (miRNA) as biomarkers capable of detecting early changes in body composition and predicting the progression of SO. MiRNAs are small noncoding RNA molecules that play a key role in regulating gene expression and cellular pathways related to inflammation, metabolism, and muscle trophism. This article summarizes current knowledge about miRNAs expression in patients with sarcopenic obesity, their regulatory functions, and their potential use in diagnostics and therapy.